首页> 外文期刊>BMC Cancer >Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway
【24h】

Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway

机译:Let-7通过调节上皮-间质转化和Wnt信号通路来抑制肝癌干细胞样细胞的自我更新

获取原文
           

摘要

Background Tumor suppressive let-7 miRNAs are universally down-regulated in human hepatocellular carcinoma (HCC) versus normal tissues; however, the roles and related molecular mechanisms of let-7 in HCC stem cells are poorly understood. Methods We examined the inhibitory effect of let-7 miRNAs on the proliferation of MHCC97-H and HCCLM3 hepatic cancer cells by using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, which was further confirmed by apoptosis and cell cycle studies. The sphere-forming assay was used to study the effects of let-7a on stem like cells. Through western blot, immunofluorescence and the luciferase-reporter assay, we explored the activity of epithelial-mesenchymal transition (EMT) signaling factors in HCC cells. qRT-PCR was applied to detect miRNA expression levels in clinical tissues. Results Let-7a effectively repressed cell proliferation and viability, and in stem-like cells, also let-7a decreased the efficiency of sphere formation.in stem-like cells. The suppression of EMT signaling factors in HCC cells contributed to let-7’s induced tumor viability repression and Wnt activation repression. Besides, Wnt1 is critical and essential for let-7a functions, and the rescue with recombinant Wnt1 agent abolished the suppressive roles of let-7a on hepatospheres. In clinical HCC and normal tissues, let-7a expression was inversely correlated with Wnt1 expression. Conclusions Let-7 miRNAs, especially let-7a, will be a promising therapeutic strategy in the treatment of HCC through eliminating HCC stem cells, which could be achieved by their inhibitory effect on the Wnt signaling pathway.
机译:背景与人类正常组织相比,在人类肝细胞癌(HCC)中普遍抑制肿瘤抑制性let-7 miRNA。然而,人们对let-7在肝癌干细胞中的作用及其相关的分子机制了解甚少。方法采用MTT(3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑鎓)测定方法,研究let-7 miRNA对MHCC97-H和HCCLM3肝癌细胞增殖的抑制作用,细胞凋亡和细胞周期研究进一步证实了这一点。球形成试验用于研究let-7a对干细胞样细胞的影响。通过蛋白质印迹,免疫荧光和荧光素酶报告法,我们探索了肝癌细胞上皮-间质转化(EMT)信号传导因子的活性。 qRT-PCR用于检测临床组织中的miRNA表达水平。结果Let-7a有效抑制细胞增殖和活力,在干细胞中,let-7a也降低了干细胞中球形成的效率。 HCC细胞中EMT信号因子的抑制导致let-7诱导的肿瘤生存抑制和Wnt激活抑制。此外,Wnt1对let-7a的功能至关重要,而用重组Wnt1试剂进行的挽救消除了let-7a对肝球的抑制作用。在临床肝癌和正常组织中,let-7a表达与Wnt1表达呈负相关。结论Let-7 miRNA,特别是let-7a,通过消除HCC干细胞将成为治疗HCC的一种有前途的治疗策略,这可以通过抑制Wnt信号通路来实现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号